Thursday, 12 September 2013

Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD

This trial of ACTH gel in 14 patients with ACE inhibitor-resistant nephrotic syndrome secondary to advanced diabetic nephropathy showed that 6 months of therapy significantly reduces proteinuria and stabilizes renal function in over half the patients (Journal of Diabetes Research)

No comments:

Post a Comment